In the latest edition of STAT's Health Tech newsletter: Cataloging generative AI...
Novartis sued in an attempt to halt Medicare drug-price negotiations, which incl...
Illumina, the largest maker of DNA-sequencing technology, named Jacob Thaysen of...
Lawmakers are likely to extend government funding later this month, but other he...
In general, the Republican presidential candidates have done little to tout thei...
Pascal Soriot: “Of course, we are here to bring medicines to patients as quickly...
“How we scale and bring the promise of cell therapy to more patients is really, ...
DOAC use may not be approved in VTE cancer patients, but GlobalData KOLs share t...
The Series C funding will support the clinical advancement of Vega Therapeutics’...
The Nordics are a well-known powerhouse of pharmaceutical innovation and product...
A new set of European Society of Cardiology (ESC) guidelines was shared at the 2...
In this 2023 study, Sjoland and other researchers found an elevated excess risk ...
Up to 45% of the trial costs for the dose-determining Phase 1b trial will be fun...
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharm...
The UK MHRA has granted marketing authorisation for AbbVie’s Aquipta (atogepant)...
The Chinese NMPA approved for AstraZeneca’s Calquence to treat chronic lymphocyt...
